MIXED DYSLIPIDEMIA
Clinical trials for MIXED DYSLIPIDEMIA explained in plain language.
Never miss a new study
Get alerted when new MIXED DYSLIPIDEMIA trials appear
Sign up with your email to follow new studies for MIXED DYSLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Omega-3 pill may boost heart health better than standard fish oil
Disease control Not yet recruitingThis study tests if a new omega-3 supplement (Ruby-O) raises omega-3 levels in the blood more than regular fish oil in adults with mixed dyslipidemia (abnormal blood fats). About 105 people on stable statin therapy will take one of three daily supplements for 24 weeks. The main g…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: NA • Sponsor: Fundación del Caribe para la Investigación Biomédica • Aim: Disease control
Last updated May 26, 2026 06:15 UTC
-
New cholesterol drug put to the test in healthy adults
Disease control Not yet recruitingThis early-stage study tests a new drug for mixed dyslipidemia (high cholesterol and fats in the blood) in 60 healthy adults. Participants will receive two different versions of the drug to compare how the body absorbs and processes them. The goal is to gather safety and drug-lev…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE1 • Sponsor: Addpharma Inc. • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Triple drug attack on artery plaque aims to prevent heart attacks
Disease control Not yet recruitingThis study tests whether a combination of three cholesterol-lowering drugs (bempedoic acid, ezetimibe, and a high-intensity statin) can shrink and stabilize plaque in the coronary arteries. It includes 103 adults with early atherosclerosis who have never had a heart attack or str…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE3 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated May 22, 2026 14:03 UTC